Clinical Study

A Double-Blinded, Randomized, Vehicle-Controlled Study of the Efficacy of Moisturizer Containing Licochalcone A, Decanediol, L-Carnitine, and Salicylic Acid for Prevention of Acne Relapse in Asian Population

Table 4

Literature review of randomized controlled studies that investigated maintenance therapy for acne compared with that of the present study.

Thiboutot et al. [34], 2005; Thiboutot et al. [31], 2006Leyden et al. [23], 2006Thielitz et al. [8], 2007Alirezai et al. [26], 2007Gold et al. [24], 2010; Poulin et al. [25], 2011The present study, 2020

Induction phase
 Number of patients46718954242459110
 Acne severitySevereModerately severe to severeMild to moderateModerate to moderately severeSevereMild to moderate
 Treatment versus gel 0.1% versus -BPO 2.5% gel versus Fixed combination of adapalene 0.1% and 100-200 mg(moderate cases)
 Duration12 weeks12 weeks8 weeks12 weeks12 weeks8 weeks
Maintenance phase
 Definition of respondersAt least 50% improvement from baselineAt least 75% improvement from baselineSubjects who successfully completed the combination phase entered the 12-week maintenance phaseAt least moderate improvement from baselineAt least 50% global improvement after a treatment phaseAt least 50% reduction in lesion counts or at least 2-grade improvements according to IGA score from baseline
 Number of patients2531104913624350 (split-face study)
TreatmentAdapalene gel 0.1% versus vehicle versus versus capsulesAdapalene daily versus adapalene in alternation with its vehicle versus vehicleAdapalene gel 0.1% versus vehicleAdapalene-BPO 2.5% gel versus vehicleMoisturizer with and without the active ingredients containing of licochalcone A, 1,2-decanediol, L-carnitine, and salicylic acid
 Duration16 weeks12 weeks12 weeks12 weeks24 weeks12 weeks
 Maintenance rateAdapalene maintenance therapy resulted in significantly larger maintenance rate of total lesions compared with vehicle (75% vs. 54%; )At week 12, more than 80% of patients in each group had maintained a 50% improvement in total lesions from baseline with no significanceAdapalene daily maintenance therapy resulted in higher maintenance rate of total lesions (68% vs. 59% vs. 41%), however no statistical significanceAdapalene maintenance therapy resulted in significantly larger maintenance rate of total lesions compared with vehicle (84.7% vs. 63.5%; )At week 24, adapalene-BPO gel resulted in significantly higher maintenance rate for total lesions (78% vs. 45.8%; )The treatment group had a significantly higher maintenance rate for mean total lesion count between baseline and week 12 (56%) compared to the vehicle group (36%) ()

Maintenance rate was defined as the percentage of patients who maintained at least 50% improvement in the total lesion count when entering the maintenance phase from baseline to the end of the study. BPO: benzoyl peroxide; IGA: Investigator’s Global Assessment.